Kirjahaku

When is doing the right thing the wrong answer?Jonathan Silverman is a well-respected attorney who finds himself drawn into the tumultuous worlds of pharmaceutical research and criminal enterprise when he's approached by a small start-up that developed a revolutionary dementia treatment seeking his help with a newly filed class-action lawsuit.As Jonathan contemplates representing the company, his father is diagnosed with early-onset Alzheimer's. Despite his world being turned upside down by the devastating prognosis, agreeing to defend the company will provide him with an opportunity to fight for a groundbreaking therapy that may help his father.As the litigation progresses, Jonathan's path collides with MJ Fernandez, an intrepid investigative reporter who questions the lawsuit's timing and the FDA's approval of a new drug by an obscure company about to launch its IPO. MJ is convinced that something is amiss with this company and their wunderkind founder. Reluctantly, they join forces to confront a ruthless investor determined to see the IPO move forward, no matter the cost.Together, they balance on the tightrope of legality in search of the truth, only to find themselves in a no-win situation and fearing for their lives and the lives of those they love.A creative yet treacherous solution emerges, but it requires Jonathan to make an impossible decision-a decision no one should ever have to make.

When is doing the right thing the wrong answer?Jonathan Silverman is a well-respected attorney who finds himself drawn into the tumultuous worlds of pharmaceutical research and criminal enterprise when he's approached by a small start-up that developed a revolutionary dementia treatment seeking his help with a newly filed class-action lawsuit.As Jonathan contemplates representing the company, his father is diagnosed with early-onset Alzheimer's. Despite his world being turned upside down by the devastating prognosis, agreeing to defend the company will provide him with an opportunity to fight for a groundbreaking therapy that may help his father.As the litigation progresses, Jonathan's path collides with MJ Fernandez, an intrepid investigative reporter who questions the lawsuit's timing and the FDA's approval of a new drug by an obscure company about to launch its IPO. MJ is convinced that something is amiss with this company and their wunderkind founder. Reluctantly, they join forces to confront a ruthless investor determined to see the IPO move forward, no matter the cost.Together, they balance on the tightrope of legality in search of the truth, only to find themselves in a no-win situation and fearing for their lives and the lives of those they love.A creative yet treacherous solution emerges, but it requires Jonathan to make an impossible decision-a decision no one should ever have to make.